This is a three-year research study for people with primary membranous nephropathy (primary MN). The study will test if combining belimumab and rituximab is effective in treating Primary MN.
Thank you for your interest, but this study is not currently enrolling.
North Carolina (Statewide)
Clinical or Medical
Kidneys and Liver